Letters

Role of spironolactone in heart failure should be emphasised

BMJ 2000; 321 doi: http://dx.doi.org/10.1136/bmj.321.7262.706 (Published 16 September 2000) Cite this as: BMJ 2000;321:706
  1. James Mapstone, specialist registrar public health medicine ([email protected]),
  2. Brian Houston, general practitioner,
  3. Mike Gogarty, deputy director of public health ([email protected])
  1. South Essex Health Authority, Brentwood CM13 3BE
  2. Highlands Surgery, Leigh on Sea SS9 2UT
  3. South Essex Health Authority, Brentwood CM13 3BE

    EDITOR—We welcome the article by Lonn and McKelvie on drug treatment in heart failure,1 which is a common and important condition. The article showed how good the evidence on the subject is. We were disappointed, however, that the role of spironolactone in improving outcomes was not discussed.

    A randomised controlled trial …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe